Etiopathological Study of Vyanga With Special Reference To Melasma And Therapeutic Trial of Kinshukadi Taila And Vatapatradi Lepa.
European Journal of Molecular & Clinical Medicine,
2020, Volume 7, Issue 11, Pages 9161-9167
Abstract
Background: Melasma is a photo-exposed hypermelanosis defined by dark brownish maculae with irregular shapes but clear borders on the face, forehead, and temples, and less often on the nose, eyelids, chin, and upper lips. As a result of air pollution, habits of using different cosmetics, stressed lifestyles, and nutritional changes and so on, many skin disorders, including melasma, are seen in our everyday lives.Aims and objective: To conduct a clinical study on raktadushṭi nidana in Vyanga. To conduct upashayatmaka (clinical) trial to assess the efficacy of Kinshukadi taila and Vatapatradi lepa in the management of Vyanga.
Material and methods: Total 100 patients were registered for the study, but 92 patients had completed the trial. : Kinshukadi Taila and Vatapatradi Lepa duration of the therapy for each group was for 60 days. This study was conducted under the following steps- Selection of patients, General observation, Administration of drug, Follow up stud, Assessment.
Result: Comparing the symptomatic improvement in both groups it was found that average percentage of relief was higher in “Group A” (21.62%) followed by Group B (15.77%). It shows that effect of therapy was more in group A in comparison to Group B. It is due to the chronic nature of disease and study duration is only two months.
Conclusion: Vatapittaja prakti, it was revealed in this study, predisposes more to Vyanga (Melasma). In a study comparing the effects of both medicines, Kinshukdi Taila and Vatapatrdi Lepa, on various signs and symptoms of Vyanga in two groups, it was discovered that “Group A” (21.62 percent) had a greater average percentage of alleviation than “Group B.” (15.77 percent).
Keywords: Melasma, Vatapittaja, Vyanga, Kinshukadi Taila, Vatapatradi Lepa.
Keywords:
- Article View: 33
- PDF Download: 11